全文获取类型
收费全文 | 4455篇 |
免费 | 381篇 |
国内免费 | 116篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 48篇 |
妇产科学 | 20篇 |
基础医学 | 136篇 |
口腔科学 | 145篇 |
临床医学 | 289篇 |
内科学 | 235篇 |
皮肤病学 | 949篇 |
神经病学 | 28篇 |
特种医学 | 94篇 |
外科学 | 565篇 |
综合类 | 484篇 |
现状与发展 | 1篇 |
预防医学 | 74篇 |
眼科学 | 264篇 |
药学 | 1147篇 |
3篇 | |
中国医学 | 374篇 |
肿瘤学 | 52篇 |
出版年
2024年 | 20篇 |
2023年 | 88篇 |
2022年 | 101篇 |
2021年 | 166篇 |
2020年 | 192篇 |
2019年 | 170篇 |
2018年 | 169篇 |
2017年 | 171篇 |
2016年 | 191篇 |
2015年 | 149篇 |
2014年 | 273篇 |
2013年 | 477篇 |
2012年 | 276篇 |
2011年 | 295篇 |
2010年 | 245篇 |
2009年 | 220篇 |
2008年 | 198篇 |
2007年 | 184篇 |
2006年 | 166篇 |
2005年 | 157篇 |
2004年 | 147篇 |
2003年 | 107篇 |
2002年 | 93篇 |
2001年 | 88篇 |
2000年 | 80篇 |
1999年 | 54篇 |
1998年 | 54篇 |
1997年 | 44篇 |
1996年 | 40篇 |
1995年 | 38篇 |
1994年 | 46篇 |
1993年 | 24篇 |
1992年 | 28篇 |
1991年 | 23篇 |
1990年 | 26篇 |
1989年 | 28篇 |
1988年 | 21篇 |
1987年 | 18篇 |
1986年 | 12篇 |
1985年 | 16篇 |
1984年 | 10篇 |
1983年 | 10篇 |
1982年 | 7篇 |
1981年 | 2篇 |
1980年 | 9篇 |
1979年 | 2篇 |
1978年 | 3篇 |
1976年 | 7篇 |
1975年 | 4篇 |
1974年 | 3篇 |
排序方式: 共有4952条查询结果,搜索用时 359 毫秒
1.
2.
ObjectiveThe purpose of this paper is to review the efficacy and safety profile in children treated with topical 0.03% Tacrolimus ointment for vernal keratoconjunctivitis in Middle East and to propose a treatment posology. According to recent studies, a complex non-IgE dependent mechanism plays a relevant role in the pathogenesis of vernal keratoconjunctivitis. Numerous cells and mediators have been found in the serum, conjunctiva and tears of patients with Vernal keratoconjunctivitis.DesignThis case series included 10 patients from a single centre, pediatric department of a tertiary hospital with active symptomatic vernal keratoconjunctivitis. All the patients had proliferative lesions and corneal involvement despite conventional medications, including topical steroids. All other medications, systemic and topical: steroids, antihistamines and cyclosporine, were unsuccessful. Patients were treated with topical 0.03% Tacrolimus ointment twice daily for 8 weeks and then once a day for the next two month followed by thrice a week for two months. The changes in symptoms and signs after treatment were evaluated, also the development of possible complications was assessed.ResultsThe results showed a significant reduction in signs and symptoms after 4 weeks of the treatment. Clinical resolution of giant papillae and corneal lesions were seen within eight weeks and no additional drug was required during that period, except tear substitutes. Treatment was continued for period of two months and then slowly reduced.ConclusionThe use of 0.03% Tacrolimus ointment is safe and effective in children refractory to conventional treatment of vernal keratoconjunctivitis even in high temperature climate as Middle East. Due to the effectiveness of the treatment, the dosage used may be proposed for conventional use. 相似文献
3.
4.
5.
Prolidase deficiency is a rare autosomal recessive disorder characterized by cutaneous ulcers, facial dysmorphism, recurrent infections, and intellectual disability. We report a unique case of a 6‐year‐old boy with prolidase deficiency and Crohn's disease who presented with lower extremity ulcers. Cutaneous ulcers due to prolidase deficiency are historically resistant to treatment, and we report success with the novel use of topical tacrolimus. 相似文献
6.
P Rubegni S Poggiali P Sbano M Risulo M Fimiani 《Journal of the European Academy of Dermatology and Venereology》2006,20(1):84-87
Tacrolimus is a macrolide that inhibits T-cell activation. The most extensive experience with topical tacrolimus has been in treating atopic dermatitis but it has been used in various skin diseases, including Hailey-Hailey disease, with encouraging results. We report a case of extensive Darier's disease successfully treated with topical tacrolimus, after suspension of oral isotretrinoin due to major depression. 相似文献
7.
8.
Shengsong Huang~ Minbin Yu~ Jie Lian~ Min Fan~ Changyu Qiu~ Zhongshan Ophthalmic Center Sun Yat-sen University Guangzhou China The Department of Ophthalmology The First Hospital of Quanzhou Fujian China 《眼科学报》2003,19(3):156-160
Purpose: To evaluate the feasibility, reliability and analgesia effect of topical anesthesia combined with subconjunctival anesthesia in anti-glaucomatous surgery.Methods: Two hundred and four cases (357 eyes) underwent anti-glaucomatous surgeries under topical anesthesia with 0.5% Alcaine eye drops combined with subconjunctival anesthesia with 2% Lidocaine. The analgesic effect was analysed with visual analogue pain scale.Results: Among all of 357 eyes, 62 eyes underwent peripheral iridectomy, 67 eyes underwent simple trabeculectomy, 167 eyes underwent compound brabeculectomy and 12 eyes nonpenetrating trabecular surgery. The effects of anesthesia were as follows: 304 eyes (85.2%) were painless (Grade Ⅰ), 50 eyes (14.0%) were slight painful (Grade Ⅱ), and 3 eyes (0.8%) were more painful (Grade Ⅲ) during surgery. And no severe complications were observed in all the cases during surgery and postoperatively. Amaurosis fugax was not observed in the glaucoma patients at the late stage with narrow vi 相似文献
9.
R.J.W. de Keizer 《International ophthalmology》1997,21(6):335-341
In a prospective study the results of a pterygium excision in 54 patients (57 eyes) who underwent a superficial free conjunctival
autograft (FCG) were compared to those of patients who were treated with postoperative90Sr-irradiation. In 51 cases the minimum
follow-up was six months, the maximum follow-up seven years. We divided the study up into a randomized part and an open part.
In the randomized part, surgery of a primary pterygium was performed in 25 eyes, of which 16 were treated with a FCG and compared
with 9 eyes with primary pterygium surgery and postoperative90Sr beta-irradiation. In the same period 16eyes were treated
because of a recurrent pterygium: 8 with FCG and 8 with90Sr-irradiation. In the open part of the study16 eyes with primary
pterygium were successively treated with FCG alone.
The results showed in the randomized, as well as in the open study on primary surgery with a minimum follow-up of six month,
one recurrence in each of the FCG-groups (2 out of 31 eyes =6.4%), and no recurrences in the 90Sr-group(0%). In the randomized
group of patients treated for a recurrent pterygium one recurrence developed in the FCG group (1 out of 8 eyes =12.5%) and
one in the 90Sr-group (1 out of 7 =14.6%). Analysis of other clinical parameters showed that postoperative treatment with
corticosteroids, nonsteroidal anti-inflammatory drugs, and artificial tears was necessary for a longer period in the FCG group
than in the90Sr-group.
This revised version was published online in August 2006 with corrections to the Cover Date. 相似文献
10.
目的总结分析1%联苯苄唑凝胶治疗婴儿花斑癣的临床疗效及不良反应。方法对22例婴儿花斑癣患者采用外用1%联苯苄唑凝胶治疗2周,总结分析其临床资料。结果外用1%联苯苄唑凝胶2周后,总有效率达到90.91%,真菌清除率达到86.36%。结论联苯苄唑凝胶治疗婴儿花斑癣安全、有效,不良反应少。 相似文献